Cipla Vice Chairman M K Hamied resigns after 47 years of service Ruchika Sharma4 Sept 2024 12:08 PM ISTMumbai: Cipla has announced the resignation of Mustafa Khwaja Hamied from the position of Vice Chairman and Non-Executive Director of the Company...
Cipla to begin supplies from China facility to US later this year Ruchika Sharma30 July 2024 12:35 PM ISTPharmaceutical giant Cipla expects to begin supplies from its China-based facility to the US market in the latter half of the current fiscal year,...
Cipla beats Q1 profit view on robust demand Ruchika Sharma27 July 2024 3:07 PM ISTHyderabad: Drugmaker, Cipla, has exceeded profit expectations for the first quarter of the fiscal year, driven by a significant increase in sales...
Cipla gets Rs 773 crore demand notice from IT Department Anshika Mishra18 July 2024 5:23 PM ISTPharmaceutical giant Cipla has disclosed that it has received a demand notice amounting to Rs 773.44 crore from the Income Tax Department. The notice...
Health Bulletin 18/ July/ 2024 Anshika Mishra18 July 2024 4:59 PM ISTHere are the top health news for the day:Maharashtra: 28 cases of zika virus reported, highest everMaharashtra has reported its highest ever number of...
IT Department sends Rs 773 crore demand notice to Cipla Ruchika Sharma17 July 2024 4:37 PM ISTMumbai: Pharmaceutical giant Cipla has disclosed that it has received a demand notice amounting to Rs 773.44 crore from the Income Tax...
USFDA classifies inspection at Cipla Kurkumbh facility as VAI Ruchika Sharma13 July 2024 2:55 PM ISTMumbai: Cipla has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the routine current...
Cipla Patalganga facility gets VAI classification from USFDA Ruchika Sharma26 Jun 2024 12:30 PM ISTMumbai: Through a recent BSE filing, Cipla has informed that the United States Food and Drug Administration (USFDA) has classified the routine...
Cipla Goa facility gets 6 USFDA observations Ruchika Sharma22 Jun 2024 3:31 PM ISTMumbai: Pharma major, Cipla, has received six inspectional observations in Form 483 from the US Food and Drug Administration (USFDA) after...
Cipla EU to infuse additional EUR 3 million in Ethris Ruchika Sharma19 Jun 2024 2:53 PM ISTMumbai: Cipla Limited has announced that its wholly-owned subsidiary in United Kingdom, Cipla (EU) Limited will invest an additional EUR 3...
Cipla bags USFDA nod for Lanreotide Injection for Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors Ruchika Sharma22 May 2024 12:35 PM ISTCipla's Lanreotide injection is indicated for the treatment of patients with Acromegaly and Gastroenteropancreatic Neuroendocrine Tumors.
Cipla to futher invest up to Rs 26 crore in Achira Labs Ruchika Sharma16 May 2024 5:30 PM ISTMumbai: Cipla Limited has announced that it has signed definitive agreements for further investment of up to Rs 26 crore (approx.) in Optionally...
